Sloan Sheldon Insider Trades

Insider Trading History

Track insider trading activity for Sloan Sheldon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $4.19M 57,027 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.6M 78,333 shares
$71.51
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $5.76M 78,333 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.44M 78,333 shares
$69.42
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $23.6M 321,667 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.44M 78,333 shares
$69.42
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $6.44M 87,542 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 7,958 shares
$48.90
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $585k 7,958 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 7,958 shares
$48.90
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$398k 7,958 shares
$50.00
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $10.3M 140,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 140,000 shares
$30.61
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $7.02M 95,500 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 95,500 shares
$21.66
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $29.4M 400,000 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11M 400,000 shares
$27.46
$73.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up